CMBA
DVAX

C.M. Bidwell & Associates’s Dynavax Technologies DVAX Stock Holding History

C.M. Bidwell & Associates’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-180
Closed -$2K – 513
2022
Q1 		$2K Buy
180
+65
+57% +$789 ﹤0.01% 474
2021
Q4 		$2K Buy
+115
New +$1.89K ﹤0.01% 517

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

C.M. Bidwell & Associates's DVAX Position: Q2 2022 in Review

C.M. Bidwell & Associates sold out of Dynavax Technologies (DVAX) in Q2 2022, closing a stake of 180 shares — an estimated $2K sold.

C.M. Bidwell & Associates first reported a position in DVAX in Q4 2021 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 209 funds tracked by Wall St. Rank hold DVAX as of Q2 2022.

  • C.M. Bidwell & Associates reported no remaining Dynavax Technologies position as of Q2 2022 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 180 Dynavax Technologies shares in Q2 2022, an estimated $2K.
  • C.M. Bidwell & Associates first reported a position in Dynavax Technologies in Q4 2021 and held it in 2 quarters.
  • C.M. Bidwell & Associates's Dynavax Technologies position peaked at $2K in Q1 2022.
  • 209 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.